Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 66.50
-0.50 (-0.75%)
Jul 30, 2026, 1:30 PM CST
Crystalvue Medical Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 912.86 | 949.05 | 868.03 | 823.96 | 795.46 | 721.61 |
Revenue Growth | 2.24% | 9.33% | 5.35% | 3.58% | 10.23% | 43.07% |
Gross Profit Gross Profit Growth | 326.68 | 331.88 | 299.14 | 266.75 | 261.74 | 211.39 |
Operating Income Operating Income Growth | 174.78 | 180.95 | 145.01 | 117.68 | 124.8 | 88.47 |
Net Income Net Income Growth | 143.88 | 146.98 | 127.15 | 103.4 | 115.03 | 77.24 |
Earnings Per Share EPS Growth | 5.58 | 5.70 | 4.95 | 4.09 | 4.51 | 3.05 |
EPS Growth | 8.17% | 15.15% | 21.03% | -9.31% | 47.98% | 37.93% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
North America North America Growth | 315.85 | 328.83 | 254.99 | 238 | 407.71 | - |
Asia Asia Growth | 243.44 | 236.21 | 226.36 | 206.01 | 182.9 | 177.79 |
Europe Europe Growth | 335.17 | 364.85 | 371.57 | 365.12 | 187.06 | - |
Others Others Growth | 18.4 | 19.17 | 15.11 | 14.83 | 17.79 | 45.62 |
Total Total Growth | 912.86 | 949.05 | 868.03 | 823.96 | 795.46 | 721.61 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 110.23 | 132.02 | 241.64 | 273.35 | 176.55 | 193.78 |
Total Debt Total Debt Growth | 9.98 | 11.7 | 18.46 | 25.03 | 31.41 | 37.61 |
Net Cash (Debt) Net Cash Growth | 100.24 | 120.31 | 223.18 | 248.32 | 145.14 | 156.17 |
Net Cash Growth | -56.14% | -46.09% | -10.12% | 71.09% | -7.06% | -61.88% |
Net Cash Per Share Net Cash Per Share Growth | 3.89 | 4.67 | 8.69 | 9.82 | 5.69 | 6.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 169.55 | 139.13 | 153.06 | 154.01 | 51.76 | 63.26 |
Capital Expenditures CapEx Growth | -235.62 | -184.04 | -130.44 | -4.37 | -7.52 | -351.17 |
Free Cash Flow Free Cash Flow Growth | -66.07 | -44.91 | 22.62 | 149.64 | 44.24 | -287.91 |
Free Cash Flow Growth | - | - | -84.89% | 238.26% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.79% | 34.97% | 34.46% | 32.37% | 32.91% | 29.29% |
Operating Margin | 19.15% | 19.07% | 16.71% | 14.28% | 15.69% | 12.26% |
Pretax Margin | 18.99% | 18.86% | 18.36% | 14.53% | 17.91% | 15.13% |
Profit Margin | 15.76% | 15.49% | 14.65% | 12.55% | 14.46% | 10.70% |
FCF Margin | -7.24% | -4.73% | 2.61% | 18.16% | 5.56% | -39.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.900 | 2.900 | 2.250 | 2.070 | 2.286 | 1.848 |
Dividend Per Share Growth | 28.89% | 28.89% | 8.70% | -9.44% | 23.71% | 38.57% |
Dividend Yield | 4.23% | 3.97% | 2.84% | 2.62% | 5.17% | 4.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.01 | 13.12 | 16.92 | 21.18 | 10.79 | 14.82 |
Forward PE | - | 15.14 | 15.14 | 16.26 | 8.26 | 8.26 |
P/FCF Ratio | - | - | 95.13 | 14.64 | 28.05 | - |
PS Ratio | 1.86 | 2.03 | 2.48 | 2.66 | 1.56 | 1.59 |